Issue link: https://beckershealthcare.uberflip.com/i/1489485
21 INNOVATION JPMorgan creates healthcare venture capital team By Naomi Diaz JPMorgan has launched a healthcare venture capital team targeting the life sciences. The team, Life Sciences Private Capital, plans to invest in early- to later-stage healthcare companies and seeks to capitalize on innovation in areas such as genetic medicine, autoimmune diseases, cardiometabolic diseases and rare disorders, according to a Nov. 1 press release from JPMorgan. A group of advisers will assist the investment team, meeting regularly and providing guidance as needed to help portfolio companies. The advisers are: • Laurie Glimcher, MD, president and CEO of the Boston-based Dana-Farber Cancer Institute • Jeffrey Leiden, MD, PhD, executive chair and former CEO of drug developer Vertex Pharmaceuticals • Frederic Moll, MD, a robotic surgery pioneer and entrepreneur who is now an executive at Johnson & Johnson • Stephen Oesterle, MD, former senior vice president for medicine and technology at medical-technology company Medtronic • Robert Stockman, co-founder and former CEO of medical device company REVA Medical n 10 most active private equity firms in healthcare By Giles Bruce P rivate equity firms that invest in healthcare had a busy first quarter of 2022, continuing a series of megadeals that started in 2021. Here are the private equity firms most active in the healthcare sector since 2017 (by deal count), according to an analysis by capital market researcher PitchBook: 1. Shore Capital Partners (Chicago): 240 2. Audax Group (Boston): 170 3. Waud Capital Partners (Chicago): 130 4. Webster Equity Partners (Waltham, Mass.): 121 5. EQT (Stockholm, Sweden): 110 6. Linden Capital Partners (Chicago): 95 7. Sheridan Capital Partners (Chicago): 79 8. KKR (New York): 79 9. TPG (Fort Worth, Texas): 77 10. HarbourVest Partners (Boston): 77 n Mayo Clinic ranked No. 1 institution for commercializing new technologies By Giles Bruce R ochester, Minn.-based Mayo Clinic was named the top research institution for spinning off new technologies, according to eco- nomic think tank Heartland Forward, in a list that included several other health systems and hospitals. Mayo Clinic, whose therapies and technologies have been licensed across the globe, produced the most startups and invention disclo- sures of any institution evaluated in the Oct. 19 report. Here are the top 10 research institutions ranked by how successfully they've brought innovations to market (scored out of a possible 100), according to the study: 1. Mayo Clinic: 100 2. Boston Children's Hospital: 91.93 3. Wistar Institute (Philadelphia): 91.14 4. University of Texas Southwestern Medical Center (Dallas): 87.01 5. Cedars-Sinai (Los Angeles) 86.22 6. Massachusetts General Hospital (Boston): 84.45 7. Memorial Sloan Kettering Cancer Center (New York City): 82.68 8. Cleveland Clinic: 81.50 9. Dana-Farber Cancer Institute (Boston): 81.30 10. Brigham and Women's Hospital (Boston) 79.72 n